Different effects of intravitreally injected ranibizumab and aflibercept on retinal and choroidal tissues of monkey eyes
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Different effects of intravitreally injected ranibizumab and aflibercept on retinal and choroidal tissues of monkey eyes
Authors
Keywords
-
Journal
BRITISH JOURNAL OF OPHTHALMOLOGY
Volume 98, Issue 6, Pages 813-825
Publisher
BMJ
Online
2014-01-24
DOI
10.1136/bjophthalmol-2013-304019
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- In vitro induction of protein complexes between bevacizumab, VEGF-A165and heparin: explanation for deposits observed on endothelial veins in monkey eyes
- (2013) Sylvie Julien et al. BRITISH JOURNAL OF OPHTHALMOLOGY
- Aflibercept for Age-Related Macular Degeneration: A Game-Changer or Quiet Addition?
- (2012) David J. Browning et al. AMERICAN JOURNAL OF OPHTHALMOLOGY
- Binding and neutralization of vascular endothelial growth factor (VEGF) and related ligands by VEGF Trap, ranibizumab and bevacizumab
- (2012) Nicholas Papadopoulos et al. ANGIOGENESIS
- Hemolysis and free hemoglobin revisited: exploring hemoglobin and hemin scavengers as a novel class of therapeutic proteins
- (2012) D. J. Schaer et al. BLOOD
- Mechanisms and Significance of Eryptosis, the Suicidal Death of Erythrocytes
- (2012) Florian Lang et al. BLOOD PURIFICATION
- Effects of bevacizumab in retina and choroid after intravitreal injection into monkey eyes
- (2012) Ulrich Schraermeyer et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Formation of immune complexes and thrombotic microangiopathy after intravitreal injection of bevacizumab in the primate eye
- (2012) Ulrich Schraermeyer et al. GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY
- Biological, Preclinical and Clinical Characteristics of Inhibitors of Vascular Endothelial Growth Factors
- (2012) Victor Chong OPHTHALMOLOGICA
- Evaluation of Age-related Macular Degeneration With Optical Coherence Tomography
- (2012) Pearse A. Keane et al. SURVEY OF OPHTHALMOLOGY
- Aflibercept in wet age-related macular degeneration: a perspective review
- (2012) Matthew Ohr et al. Therapeutic Advances in Chronic Disease
- Preclinical aspects of anti-VEGF agents for the treatment of wet AMD: ranibizumab and bevacizumab
- (2011) C H Meyer et al. EYE
- Characterization and allelic polymorphisms of rhesus macaque (Macaca mulatta) IgG Fc receptor genes
- (2011) Doan C. Nguyen et al. IMMUNOGENETICS
- Complement activation by (auto-) antibodies
- (2011) Nina A. Daha et al. MOLECULAR IMMUNOLOGY
- Fc-Glycosylation Influences Fc Receptor Binding and Cell-Mediated Anti-HIV Activity of Monoclonal Antibody 2G12
- (2010) D. N. Forthal et al. JOURNAL OF IMMUNOLOGY
- Effect of Daily Prolonged Ketamine Anesthesia on Intraocular Pressure in Monkeys
- (2009) Theodora J. Bunch et al. CURRENT EYE RESEARCH
- An essential role for RPE-derived soluble VEGF in the maintenance of the choriocapillaris
- (2009) M. Saint-Geniez et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Short-term intraocular pressure trends following intravitreal injections of ranibizumab (Lucentis) for the treatment of wet age-related macular degeneration
- (2008) G Mojica et al. BRITISH JOURNAL OF OPHTHALMOLOGY
- Bevacizumab immune complexes activate platelets and induce thrombosis in FCGR2A transgenic mice
- (2008) T. MEYER et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started